Adial Pharmaceuticals, Inc. (ADIL) Daily Stock Prediction

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

8

Address:

Adial Pharmaceuticals, Inc. 1180 Seminole Trail Suite 495 Charlottesville VA 22901 United States

Website:

http://www.adialpharma.com

Phone:

434-422-9800